Three major changes combed! Supply chain reform in the whole industry chain of drug research and development, production and purchase"
This year, "double 11", CFDA issued the "8 companies on 11 applications for drug registration approval" (2015 229th), so that the entire pharmaceutical industry shocked. However, the day before the double 11, the highest national leaders for the first time put forward "supply side structural reforms", half a month so far has frequently stressed that "supply side reforms" have recently become one of the hot areas of economic Chinese words.
Learn More >